Poly‐<scp>d</scp>,<scp>l</scp>‐Lactic Acid Via Transdermal Microjet Drug Delivery for Treating Rosacea in Asian Patients
Injectable PDLLA delivered via laser-induced microjet injection demonstrated promising efficacy in improving rosacea symptoms and skin quality for up to 22 weeks without significant adverse effects. Larger randomized controlled trials are needed to confirm these findings and evaluate long-term safety and sustainability of outcomes.
Authors
- Jesper Thulesen (ORCID: https://orcid.org/0000-0002-5355-8062)
- Arash Jalali (ORCID: https://orcid.org/0000-0002-7263-4745)
- Suk Bae Seo
- Massimo Vitale (ORCID: https://orcid.org/0000-0001-5372-7885)
- Kyu‐Ho Yi (ORCID: https://orcid.org/0000-0001-5572-1364)
- Soo‐Bin Kim (ORCID: https://orcid.org/0000-0003-2576-5723)
- Jovian Wan (ORCID: https://orcid.org/0009-0003-2507-4524)
Institutions
- Yonsei University (KR)
- Vancouver Clinic (US)
- Yonsei University College of Dentistry
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1111/jocd.16556
- Citations
- 6
- Primary Topic
- Acne and Rosacea Treatments and Effects
- Type
- article
- Field-Weighted Citation Impact
- 3.21